Cent Eur J Public Health 2020, 28(3):246-247 | DOI: 10.21101/cejph.a6464

Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?

Mohamed Farouk Allam, Fady Andraous
Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Vloženo: 1. červenec 2020; Revidováno: 11. srpen 2020; Přijato: 11. srpen 2020; Zveřejněno: 30. září 2020  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Allam MF, Andraous F. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical? Cent Eur J Public Health. 2020;28(3):246-247. doi: 10.21101/cejph.a6464. PubMed PMID: 32997483.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. McIntosh K. Coronavirus disease 2019 (COVID-19): epidemiology, virology, and prevention [Internet]. Waltham: UpToDate; 2020 [cited 2020 Aug 8]. Available from: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19.
    2. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). Information for clinicians on investigational therapeutics for patients with COVID-19 [Internet]. Atlanta: CDC; 2020 [cited 2020 Aug 8]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html.
    3. European Medicines Agency. COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes [Internet]. Amsterdam: European Medicines Agency; 2020 [cited 2020 Aug 8]. Available from: https://www.ema.europa.eu/en/news/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes.
    4. Mendel A, Bernatsky S, Askanase A, Bae SC, Clarke AE, Costedoat-Chalumeau N, et al. Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics. Ann Rheum Dis. 2020 Jun 25;annrheumdis-2020-218164. doi: 10.1136/annrheumdis-2020-218164. Přejít k původnímu zdroji... Přejít na PubMed...
    5. Plüß M, Chehab G, Korsten P. Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey. Ann Rheum Dis. 2020 Jul 2;annrheumdis-2020-217967. doi: 10.1136/annrheumdis-2020-217967. Přejít k původnímu zdroji... Přejít na PubMed...
    6. Juurlink DN. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. CMAJ. 2020 Apr 27;192(17):E450-3. Přejít k původnímu zdroji... Přejít na PubMed...
    7. Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 May 1;e201834. doi: 10.1001/jamacardio.2020.1834. Přejít k původnímu zdroji... Přejít na PubMed...
    8. Jankelson L, Karam G, Becker ML, Chinitz LA, Tsai MC. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review. Heart Rhythm. 2020 Sep;17(9):1472-9. Přejít k původnímu zdroji... Přejít na PubMed...
    9. Randomised Evaluation of COVID-19 Therapy (RECOVERY). Statement from the chief investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine, 5 June 2020. No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 [Internet]. [cited 2020 Aug 8]. Available from: https://www.recoverytrial.net/files/hcq-recovery-statement-050620-final-002.pdf.
    10. McCall R. Some Swedish hospitals have stopped using chloroquine to treat covid-19 after reports of severe side effects. Newsweek [Internet]. 2020 Sep 14 [cited 2020 Aug 8]. Available from: https://www.newsweek.com/swedish-hospitals-chloroquine-covid-19-side-effects-1496368.
    11. Prevention and treatment of COVID-19 with chloroquine or hydroxychloroquine [Internet]. Ottawa: Canadian Pharmacists Association; 2020 [cited 2020 Aug 8]. Available from: https://www.pharmacists.ca/cpha-ca/assets/File/cpha-on-the-issues/CQ-HCQ-COVID-FINAL-EN.pdf.
    12. Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, et al.; CloroCovid-19 Team. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A randomized clinical trial. JAMA Netw Open. 2020 Apr 1;3(4):e208857. doi: 10.1001/jamanetworkopen.2020.8857. Přejít k původnímu zdroji... Přejít na PubMed...
    13. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. doi:10.1016/j.ijantimicag.2020.105949. Přejít k původnímu zdroji... Přejít na PubMed...
    14. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Sevestre J, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020;34:101663. doi:10.1016/j.tmaid.2020.101663. Přejít k původnímu zdroji... Přejít na PubMed...
    15. Huang M, Li M, Xiao F, Pang P, Liang J, Tang T, et al. Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19. Natl Sci Rev. 2020 Sep 1;7(9):1428-36. Přejít k původnímu zdroji... Přejít na PubMed...
    16. U.S. Food and Drug Administration. Coronavirus (COVID-19) update: FDA revokes emergency use authorization for chloroquine and hydroxychloroquine [Internet]. Silver Spring: FDA; 2020 [cited 2020 Aug 8]. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and.
    17. ClinicalTrials.gov. Clinical studies related to COVID-19 [Internet]. [cited 2020 Aug 8]. Available from: https://clinicaltrials.gov/ct2/results?cond=COVID-19.

    Zpět na obsah